cervical cancer
Researchers have begun validating the new method that can reduce lab contamination and obviate the need for lyophilization.
Teal Health Closes $10M in Seed Funding to Support Self-Collected Cervical Cancer Test
The at-home collection device is for the detection of human papillomavirus and recently received breakthrough device designation from the FDA.
Becton Dickinson's HPV assay was FDA-approved for use with clinician-collected samples in 2018 and received approval for sample self-collection in May.
Predica Diagnostics Developing Targeted Sequencing Test for Cervical Cancer Diagnosis, Screening
Premium
The test is based on targeted circular probe-based RNA next-generation sequencing (ciRNAseq), which enables a high degree of multiplexing and mutational analysis.
MGI Tech, Predica Diagnostics Partner to Develop RNA-Based Cancer Screening Tests
The companies will combine Predica’s proprietary circular probe-based RNA-seq technology with MGI’s DNBSeq platforms for early cancer detection.
Jan 29, 2024
Oct 28, 2021
Mar 16, 2021